The 503A patient-specific pathway remains intact, but the large-scale 503B pathway is under active regulatory action
Right now, the evidence supporting this potential benefit is little more than anecdotal
Semaglutide may make formerly favorite foods seem disgusting While semaglutide helps with weight loss by reducing appetite, some patients have reported it seems to work too well, preventing them from enjoying food they used to love
This table outlines the search strategies implemented in PubMed/MEDLINE, Embase, and Scopus databases to find the relevant randomized controlled trials (RCTs) on GLP-1 receptor agonists and gastrointestinal cancers
Is this just a coincidence, or a sign that were moving too fast
The relationship between dose and effect was close to linear across the studied range